First Human Trial of Targeting MDM2/MDMX PET Imaging

Clinical trial NCT06443762 · COMPLETED

Trial details

NCT number: NCT06443762
Sponsor: Peking University Cancer Hospital & Institute
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

MDM2/MDMX Gene Mutation Nuclear Medicine Positron Emission Tomography Imaing

Start date: 2025-01-03
Primary completion: 2025-05-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.